603260.Ss

The company's capital structure shows a debt-to-equity ratio of 1.13, indicating moderate leverage. With a current ratio of 0.33, the company faces liquidity constraints, as current assets significantly lag behind current liabilities. The price-to-book ratio of 1.64 suggests the market values the company at a premium to its book value, but this is partially offset by negative returns on equity (-10.23%) and assets (-3.58%).

Profitability metrics reveal significant underperformance relative to industry norms. The company reported a net loss of CNY 2.99 billion and operating loss of CNY 2.63 billion, with a gross profit of only CNY 1.08 billion on CNY 20.5 billion in revenue. These results indicate operational inefficiencies and pricing pressures in the specialty chemicals market.

Geographic and segment exposure data is not available in the provided dataset. However, the company's revenue concentration in a single business line (specialty chemicals) creates operational risk if demand for chemical products declines in key markets.

Growth trajectory analysis shows negative momentum. The company's free cash flow is negative at CNY -1.87 billion, and operating cash flow of CNY 4.01 billion is insufficient to cover capital expenditures of CNY 1.19 billion. With a price target range of CNY 52.62 to CNY 55.00, analysts expect a 27-33% price appreciation from current levels.

Risk factors include liquidity constraints (current ratio of 0.33) and negative net cash position after debt. The company has low dilution risk with basic and diluted shares outstanding aligned at 1.18 billion shares. No material dilution adjustments were applied in valuation models.

Recent filings show deteriorating profitability with consecutive losses in operating and net income. The company's capital expenditure of CNY 1.19 billion indicates ongoing investment in production capacity, but this is not offsetting declining margins.